• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Rett Syndrome - Articles and news items

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Industry news / 18 May 2016 / Mandy Parrett, Editorial Assistant

Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +